These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22952796)

  • 1. Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition.
    West JM; Zvonok N; Whitten KM; Vadivel SK; Bowman AL; Makriyannis A
    PLoS One; 2012; 7(8):e43877. PubMed ID: 22952796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Structure-Activity Relationships of Isothiocyanates as Potent and Selective
    Malamas MS; Pavlopoulos S; Alapafuja SO; Farah SI; Zvonok A; Mohammad KA; West J; Perry NT; Pelekoudas DN; Rajarshi G; Shields C; Chandrashekhar H; Wood J; Makriyannis A
    J Med Chem; 2021 May; 64(9):5956-5972. PubMed ID: 33900772
    [No Abstract]   [Full Text] [Related]  

  • 3. Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.
    West JM; Zvonok N; Whitten KM; Wood JT; Makriyannis A
    J Proteome Res; 2012 Feb; 11(2):972-81. PubMed ID: 22040171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights in the mechanism of action and inhibition of N-acylethanolamine acid amidase by means of computational methods.
    Lodola A; Rivara S; Mor M
    Adv Protein Chem Struct Biol; 2014; 96():219-34. PubMed ID: 25443959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
    Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
    ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
    Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
    J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
    Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
    PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
    Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
    Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies.
    Pavlopoulos S; Pelekoudas DN; Benchama O; Rawlins CM; Agar JN; West JM; Malamas M; Zvonok N; Makriyannis A
    Protein Expr Purif; 2018 May; 145():108-117. PubMed ID: 29253688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.
    Armirotti A; Romeo E; Ponzano S; Mengatto L; Dionisi M; Karacsonyi C; Bertozzi F; Garau G; Tarozzo G; Reggiani A; Bandiera T; Tarzia G; Mor M; Piomelli D
    ACS Med Chem Lett; 2012 May; 3(5):422-6. PubMed ID: 24900487
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel activity-based probes for N-acylethanolamine acid amidase.
    Petracca R; Romeo E; Baggelaar MP; Artola M; Pontis S; Ponzano S; Overkleeft HS; van der Stelt M; Piomelli D
    Chem Commun (Camb); 2017 Aug; 53(86):11810-11813. PubMed ID: 29035406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6.
    Shields CM; Zvonok N; Zvonok A; Makriyannis A
    Sci Rep; 2019 Jan; 9(1):890. PubMed ID: 30696836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
    Bottemanne P; Muccioli GG; Alhouayek M
    Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.